Form: 20-F

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Exhibit 8.1

Company Subsidiaries

Novogen Limited is a company limited by shares and is incorporated and domiciled in Australia. Novogen Limited has prepared a consolidated financial report incorporating the entities that it controlled during the financial year ended June 30, 2016, which included the following:

 

Name of entity   

Country of incorporation

   Equity
holding
%
 

Novogen Laboratories Pty Ltd

   Australia      100.00   

Novogen Research Pty Ltd

   Australia      100.00   

Novogen North America Inc.

   United States (Delaware)      100.00   

Triaxial Pharmaceuticals Pty Ltd

   Australia      100.00